Across TCGA pan-cancer cohorts, MIR548F1 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR548F1 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher MIR548F1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548F1 expression acts as an unfavorable survival marker.

ESCA and BLCA are the cancer types where MIR548F1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	II,III,IV	0.117	0.703	<.001	108	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR548F1 tumor-vs-normal RNA expression · all MIR548F1 data types